Pipeline Therapeutics
Founded Year
2017Stage
Series C | AliveTotal Raised
$110MLast Raised
$80M | 1 yr agoAbout Pipeline Therapeutics
Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecules for neuroregeneration.
Pipeline Therapeutics Headquarter Location
10578 Science Center Drive Ste. 200
San Diego, California, 92121,
United States
858-333-5280
Expert Collections containing Pipeline Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pipeline Therapeutics is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Pipeline Therapeutics Patents
Pipeline Therapeutics has filed 5 patents.
The 3 most popular patent topics include:
- Audiology
- Auditory system
- Ear
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/12/2017 | 2/23/2021 | Auditory system, Ear, Audiology, Hearing, Ear procedures | Grant |
Application Date | 12/12/2017 |
|---|---|
Grant Date | 2/23/2021 |
Title | |
Related Topics | Auditory system, Ear, Audiology, Hearing, Ear procedures |
Status | Grant |
Latest Pipeline Therapeutics News
May 11, 2022
May 11, 2022 04:05 PM Eastern Daylight Time SAN DIEGO--( BUSINESS WIRE )--Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that company management will present at the following investor conferences: 2022 RBC Capital Markets Global Healthcare Conference Wednesday, May 18, 2022 at 8:00 am ET UBS Global Healthcare Conference About Pipeline Therapeutics Pipeline Therapeutics is a clinical-stage biopharmaceutical company pioneering the development and commercialization of first-in-class therapies for precision neuroregeneration including myelin restoration, synaptogenesis and axonal repair. The Company has a broad pipeline of programs to address CNS and neuro-otology conditions. Its flagship program, PIPE-307, has completed a Phase 1 clinical trial in healthy volunteers and has received IND clearance from the FDA to initiate a Phase 1b/2a trial in relapsing-remitting MS patients. For more information, please visit www.pipelinetherapeutics.com and engage with us on LinkedIn. Contacts
Pipeline Therapeutics Web Traffic
Pipeline Therapeutics Rank
When was Pipeline Therapeutics founded?
Pipeline Therapeutics was founded in 2017.
Where is Pipeline Therapeutics's headquarters?
Pipeline Therapeutics's headquarters is located at 10578 Science Center Drive, San Diego.
What is Pipeline Therapeutics's latest funding round?
Pipeline Therapeutics's latest funding round is Series C.
How much did Pipeline Therapeutics raise?
Pipeline Therapeutics raised a total of $110M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.